MWM
REGN icon

Meridian Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Meridian Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-523
Closed -$274K – 723
2025
Q2 		$274K Sell
523
-399
-43% -$223K 0.01% 574
2025
Q1 		$585K Hold
922
– – 0.03% 382
2024
Q4 		$657K Sell
922
-97
-10% -$81.4K 0.03% 362
2024
Q3 		$1.07M Buy
1,019
+55
+6% +$61.2K 0.05% 273
2024
Q2 		$1.01M Buy
+964
New +$935K 0.12% 114
2024
Q1 		– Sell
-994
Closed -$873K – 433
2023
Q4 		$873K Buy
994
+91
+10% +$74.9K 0.06% 280
2023
Q3 		$743K Sell
903
-4
-0.4% -$3.14K 0.05% 287
2023
Q2 		$652K Buy
907
+85
+10% +$65.5K 0.05% 275
2023
Q1 		$675K Buy
822
+487
+145% +$367K 0.06% 269
2022
Q4 		$242K Buy
+335
New +$247K 0.02% 459
2020
Q4 		– Sell
-540
Closed -$302K – 346
2020
Q3 		$302K Sell
540
-1,034
-66% -$627K 0.07% 187
2020
Q2 		$981K Buy
1,574
+1,004
+176% +$570K 0.33% 68
2020
Q1 		$278K Buy
+570
New +$235K 0.12% 159

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meridian Wealth Management's REGN Position: Q3 2025 in Review

Meridian Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 523 shares — an estimated $274K sold.

Meridian Wealth Management first reported a position in REGN in Q1 2020 and held it in 13 quarters. The position peaked at $1.07M in Q3 2024. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Meridian Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Meridian Wealth Management sold 523 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $274K.
  • Meridian Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 13 quarters.
  • Meridian Wealth Management's Regeneron Pharmaceuticals position peaked at $1.07M in Q3 2024.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Meridian Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.